Discount Agreement for Choriongonadotropin alfa
Original notice title
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2025-10 - Choriongonadotropin alfa
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
No estimated value or framework maximum is provided. Bidders cannot assess potential revenue or pricing strategy.
Since all qualified applicants can participate, many competitors may join, potentially limiting market share for each c...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until May 2027
- Supply of pharmaceutical products containing Choriongonadotropin alfa to patients insured by TK, HEK, and hkk.
- Conclusion of a discount agreement under § 130a Abs. 8 SGB V with uniform terms for all participating pharmaceutical entrepreneurs.
Show full summary
This is an Open House procedure by Techniker Krankenkasse (TK) and associated health insurers for discount agreements on the active substance Choriongonadotropin alfa. The contract is open to all qualified pharmaceutical entrepreneurs under uniform terms, with no exclusivity. The maximum contract duration is 24 months from June 1, 2025 to May 31, 2027. Submissions can be made at any time during the period, but must be submitted via email with qualified electronic signature or by post. The estimated contract value is not provided. The notice clarifies this is not a public procurement procedure under EU directives; legal challenges fall under social courts.
Risks
No estimated value or framework maximum is provided. Bidders cannot assess potential revenue or pricing strategy.
Since all qualified applicants can participate, many competitors may join, potentially limiting market share for each c...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur within the meaning of § 4 Abs. 18 AMG for the offered medicinal product.
- Must have a registered office in Germany, another EU member state, or a EEA state (§ 9 Abs. 2 Satz 1 AMG).
- Must hold a valid marketing authorisation for the relevant medicinal product or be otherwise entitled to place it on the market.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Discount Agreement for Choriongonadotropin alfa
Open House procedure for concluding discount agreements with all suitable pharmaceutical entrepreneurs for the active substance Choriongonadotropin alfa. Uniform terms apply; no exclusivity is granted.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria defined
the Open House procedure does not involve a competitive award. All qualified participants may conclude a contract.
Value note
Show original TED data
Original lot title
Open House Biologika Rabattverträge 2025-10 - Choriongonadotropin alfa
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zum Wirkstoff Choriongonadotropin alfa zu schließen.
Procurement Details
- Publication date
- 22 Apr 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 262953-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
No estimated value or framework maximum is provided. Bidders cannot assess potential revenue or pricing strategy.
Since all qualified applicants can participate, many competitors may join, potentially limiting market share for each c...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications